🇺🇸 Qdenga in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 10
Most-reported reactions
- Benign Prostatic Hyperplasia — 1 report (10%)
- Cardiogenic Shock — 1 report (10%)
- Condition Aggravated — 1 report (10%)
- Contraindicated Product Administered — 1 report (10%)
- Dengue Fever — 1 report (10%)
- Dengue Virus Test Positive — 1 report (10%)
- Diverticulum — 1 report (10%)
- Drug Ineffective — 1 report (10%)
- Dysbiosis — 1 report (10%)
- Gastrooesophageal Reflux Disease — 1 report (10%)
Other Other approved in United States
Frequently asked questions
Is Qdenga approved in United States?
Qdenga does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Qdenga in United States?
IRCCS Sacro Cuore Don Calabria di Negrar is the originator. The local marketing authorisation holder may differ — check the official source linked above.